✦ LIBER ✦

HER-2/neu Overexpression and Tumor Subtyping: Is there an Increased Risk of Axillary Node Positivity in Early Stage Breast Cancer?

✍ Scribed by M.A. Hallman; G.M. Freedman; R.J. Bleicher; T. Li; P.R. Anderson; E.R. Sigurdson; R. Swaby; H. Dushkin; L.J. Goldstein

Book ID: 118456174
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The University of Florida Experience wit

The University of Florida Experience with HER2-Positive Stage I-III Breast Cancers: Is there an Increased Risk of Local-regional Recurrence?

✍ E.L. Swanson; N.P. Mendenhall; C.G. Morris; J.L. Lightsey 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Relapse rates and patient outcome in bre

Relapse rates and patient outcome in breast cancer patients with 1–3 positive axillary lymph nodes. Is there an impact of axillary extracapsular tumor extension (ECE) on local and/or distant control?

✍ H. Stranzl; Peintinger; P. Ofner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m

Doxorubicin and cyclophosphamide adjuvan

Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer: There is no clear evidence that HER-2 status affects the relative effects of doxorubicin and cyclophosphamide vs cyclophosphamide, methotrexate and 5-fluorouracil in women with operable breast cancer

✍ Dino Amadori 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB